Literature DB >> 27458685

Osteoprotective Effects of Polysaccharide-Enriched Hizikia fusiforme Processing Byproduct In Vitro and In Vivo Models.

Yong Tae Jeong1, Seung Hwa Baek2, Sang Chul Jeong3, Yeo Dae Yoon4, Ok Hee Kim5, Byung Chul Oh5, Ji Wook Jung6, Jin Hee Kim7.   

Abstract

The traditional manufacturing method used to produce goods from Hizikia fusiforme, utilizes extraction steps with hot water. The byproduct (of hot water extraction) is rich in polysaccharide and is considered a waste. To evaluate the osteogenic effects of the byproduct of H. fusiforme (HFB), osteogenic cells and animal models were used to test it effects on osteogenesis. The HFB-treated mouse myoblast C2C12 cells exhibited significant dose dependently elevated alkaline phosphatase (ALP) activity and slightly increased bone morphogenetic protein-2 (BMP-2). HFB also suppressed the formation of tartrate-resistant acid phosphatase (TRAP) activity and TRAP staining in the bone marrow-derived macrophages (BMM) cells that had been stimulated with the receptor activator of the nuclear factor kB ligand/macrophage colony-stimulating factor kB ligand. In addition, HFB also increased the phosphorylation of extracellular signal-regulated protein kinase (p-ERK) level. Finally, osteogenic effects of HFB were clearly confirmed in the three in vivo models: zebrafish, ovariectomized mice, and mouse calvarial bones. HFB accelerated the rate of skeletal development in zebrafish and prevented much of the mouse femoral bone density loss of ovariectomized mice. Moreover, HFB enhanced woven bone formation over the periosteum of mouse calvarial bones. Our result showed that HFB functions as a bone resorption inhibitor as well as an activator of bone formation in vivo and in osteogenic in vitro cell systems.

Entities:  

Keywords:  Hizikia fusiforme; osteoblast; osteoclast; ovariectomized mice; zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27458685     DOI: 10.1089/jmf.2015.3646

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  6 in total

1.  The Brown Algae Ishige sinicola Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos.

Authors:  Mihyang Kim; Mihwa Park
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

2.  In Vitro and In Vivo Antitumor Efficacy of Hizikia fusiforme Celluclast Extract against Bladder Cancer.

Authors:  Jun-Hui Song; Se Yeon Won; Byungdoo Hwang; Soontag Jung; Changsun Choi; Sung-Soo Park; Yung Hyun Choi; Wun-Jae Kim; Sung-Kwon Moon
Journal:  Nutrients       Date:  2020-07-21       Impact factor: 5.717

Review 3.  Bioactive Compounds from Marine Organisms: Potential for Bone Growth and Healing.

Authors:  Matthew A Carson; Susan A Clarke
Journal:  Mar Drugs       Date:  2018-09-18       Impact factor: 5.118

4.  Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis.

Authors:  Vrathasha Vrathasha; Hilary Weidner; Anja Nohe
Journal:  Int J Mol Sci       Date:  2019-05-21       Impact factor: 5.923

5.  Ethanol Extract of Hizikia fusiforme Induces Apoptosis in B16F10 Mouse Melanoma Cells through ROS-Dependent Inhibition of the PI3K/Akt Signaling Pathway.

Authors:  Cheol Park; Hyesook Lee; Hyun Hwangbo; Seon Yeong Ji; Min Yeong Kim; So Young Kim; Su Hyun Hong; Gi-Young Kim; Yung Hyun Choi
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

Review 6.  A concise review of the bioactivity and pharmacological properties of the genus Codium (Bryopsidales, Chlorophyta).

Authors:  Maria Dyah Nur Meinita; Dicky Harwanto; Jae-Suk Choi
Journal:  J Appl Phycol       Date:  2022-10-13       Impact factor: 3.404

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.